| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T767 |
0-222 |
Sentence |
denotes |
In 2004, SARS patients in an open‐label study had better clinical outcomes when treated with ribavirin in combination with lopinavir‐ritonavir (400 and 100 mg, respectively) than the control group receiving only ribavirin. |
| T768 |
223-357 |
Sentence |
denotes |
227 A study in SARS patients found that viral replication could not be blocked at ribavirin concentrations achievable in human serum. |
| T769 |
358-486 |
Sentence |
denotes |
234 Nevertheless, the combination of ribavirin with IFN‐β had a synergistic effect on the inhibition of SARS‐CoV‐1 replication. |
| T770 |
487-596 |
Sentence |
denotes |
The effects of PEGylated IFN together with ribavirin against SARS‐CoV‐2 are being studied in clinical trials. |
| T771 |
597-599 |
Sentence |
denotes |
87 |
